Senior Management Team


Dr. Wilson KL WONG, PhD

CEO / Founder

Dr Wong has extensive experiences in biomechanics and biomaterial researches with numerous publications on high impact journals such as Biomaterials. He is the Winning Solver of InnoCentive, a global leader in crowdsourcing innovation problems. He has strong networks in research communities in Hong Kong. He had served in the Court and the Senate in the University of Hong Kong for three years. He is the CEO and oversees the overall growth and development of the company.

Dr Wong holds a PhD in Bioengineering from the University of Hong Kong.

 

Dr. Kenneth KY LAI, PhD

Executive Director / Founder

Dr Lai is an enthusiastic young scientist with extensive experiences in the fields of pharmacology, immunology, virology and oncology. Previously, he worked in GenePro DNAgnostic Technology Limited, where he was heading the paternity testing department. He has published more than 10 international journal articles as well as invited book chapters. He also holds a patent in the University of Hong Kong as one of the co-inventors. At NOVUS, he is responsible for overseeing the research and development projects and coordinating between different collaboration parties.

Dr Lai holds a PhD in Cancer Research from the University of Hong Kong.

 

Dr. Nicholas CL WONG, PhD

Executive Director / Founder

Dr Wong is an oncology expert. He worked as an application specialist for IVD products in oncology and virology at Roche Diagnostic Hong Kong. He is currently the project manager at a drug development company in Shanghai where he is in charge for the development of novel therapeutics for liver cancers. He has extensive connections with different academic institutes and venture capitals in China. He is responsible for managing the strategic partnerships of NOVUS in China.

Dr Wong holds a PhD in Cancer Research from the University of Hong Kong.

 

Mr Vernon LL TAM

Consultant / Founder

Mr Tam has over 8 years of experiences in investment banking and the healthcare sector. He had led and participated in several IPOs and corporate financing projects of many biomedical and healthcare companies. Prior to joining the investment banking industry, he has extensive industry experiences in working for big pharma such as Eli Lilly and Merck.

Mr Tam holds a Bachelor of Science and a Master of Philosophy in Biomedical Sciences Research from The University of Hong Kong. He holds a MBA from The Chinese University of Hong Kong.

 

Mr Joseph KC SHAU, CFA, FRM

Executive Director / Founder

Mr Shau has over 7 years of experiences in investment banking and corporate finance. He had led and participated in several equity and debt financing projects, M&A and restructuring activities. He provides financial and operational advices to a broad client base with a focus in the healthcare sector.

Mr Shau holds a Bachelor of Economics from Peking University. He is a Chartered Financial Analyst (CFA) and a Financial Risk Manager (FRM).